Quick Take – What Sort of Deceptive Nonsense is Cytodyn Spewing Now? (CYDY)

Finally, it is the 21st of July and the long awaited trial “results” from everyone’s favorite reverse-merger pink sheet Coronacrapper, Cytodyn (CYDY) have arrived! Well, not really, because the company didn’t really announce any real results this morning (read more about that here). What The NaDDir* did announce was a collection of bizarre ramblings about wonder drug leronlimab‘s supposed safety from the Phase 2 trial of leronlimab in mild/moderate Covid patients (trial details here).

From this morning’s press release:

CYDY-Results1

The headline? Impressive Results….39% of patients in (the) placebo arm had SAEs as compared to only 14% of patients in (the) leronlimab arm.

More like impressive bullshit. Just a few lines later one can see that 6 out of 28 patients in the placebo arm, and 5 out of 56 patients in the leronlimab arm reported SAEs. That’s actually 21.4% and 8.9%.

Coming from the same klown krew who still can’t manage to file an acceptable BLA submission, is their failure to do simple math much of a surprise? Or was this a deliberate deception to make leronlimab somehow look more appealing in front of tomorrow’s shareholder meeting where management is hoping to get another 100mm shares authorized so the dilution can continue unimpeded.

*Spelled thusly for a double dose of that sweet sweet stock pimping.

THE CONTENT CONTAINED IN THIS BLOG REPRESENTS ONLY THE OPINIONS OF THE AUTHOR. THE AUTHOR MAY HOLD EITHER LONG OR SHORT POSITIONS IN SECURITIES OF VARIOUS COMPANIES DISCUSSED IN THE BLOG. THIS COMMENTARY IN NO WAY CONSTITUTES INVESTMENT ADVICE, AND SHOULD NEVER BE RELIED ON IN MAKING AN INVESTMENT DECISION, EVER. THIS BLOG IS NOT A SOLICITATION OF BUSINESS: ALL INQUIRIES WILL BE IGNORED. THE CONTENT HEREIN IS INTENDED SOLELY FOR THE ENTERTAINMENT OF THE READER, AND THE AUTHOR.

 

5 comments

  1. Stock hacking for the mentally impaired. A little DD would expose you as a fraud to anyone who investigates your bogus claims.

    [Yes Clyde. Anyone dumb enough to be a Cytodyn shareholder is likely mentally impaired. And yes, The NaDDir’s ridiculous claims have time and again been proven to be completely bogus. – Editor]

  2. More garbage from the idiots over there at buyer’s strike. Inanity on display for all to see. You really have no idea what you’re talking about, do you? Expect a knock on the door any day from the SEC and/or the Feds. We have people on it right now.

    [Sure you do. – Editor]

  3. Your use of the term The NaDDir is also extremly offensive and borderline racist. But you knew that already. Sleep well, turds.

    [Waaaaah! Some bagholding soyboy from the San Antonio University Health System is whining about racism. Get a refund on your Grievance Study classes and take a math class. – Editor]

  4. Yeah the fda allows con men and companies to do drug trials. Shut up idiot.

    [Yes, they do actually. Quite often. If you can manage to fill out an IND correctly, and you have the cash to pay the hospitals their fees, anyone can do a clinical trial. Con men and craptacular reverse merger scam companies included. – Editor]

Leave a Reply to Clyde Cancel reply